Nexus Venture Partners

Nexus Venture Partners is one of India’s most established early-stage firms, with offices in Mumbai, Bangalore, and Menlo Park, and a portfolio that includes Postman, Druva, Delhivery, Pubmatic, Unacademy, Rapido, and a deep bench of enterprise and consumer companies that have produced public-market and large-strategic exits. The firm operates a genuinely cross-border practice: Indian founders building global products are core, and US founders with India connections (engineering teams in India, India-to-US founder pairs) are equally welcome. For healthcare and AI founders, Nexus has been a meaningful digital health investor in India, with portfolio companies including myUpchar (consumer health and pharmacy), CrelioHealth (laboratory information systems and diagnostics workflow), and Ember (digital health platform), and the firm has stated digital health, healthcare software, and AI/ML in healthcare as explicit thesis areas. Stage focus is seed, Series A, and Series B, with check sizes in the one-to-five-million range at first entry and reserves to follow through Series B; the firm leads rounds at its check size and is willing to be the only institutional investor in a seed round when conviction is high. Geography is India-headquartered with a Menlo Park office for cross-border deal flow and selected US-based bets where the team has India connections. Founders who should approach Nexus are Indian healthcare-tech founders building software, AI applications, or digital health platforms; cross-border founders building products for global markets from India; and US founders with India engineering teams who want a partner who can credibly help with the India operations. Founders who should look elsewhere are pure US-only founders without an India connection (the firm’s network and operating bench are India-centric, and a US-only founder will get more from a US-only firm), and clinical-stage biotech and devices founders, which are not the firm’s category. The entry path that works best is a warm intro through a portfolio CEO or through the Indian startup ecosystem (accelerators, ecosystem events, India-based VCs) where Nexus is well-networked. When you pitch, lead with the market thesis and the team’s reason to believe, with an honest read on the India regulatory and payer environment if the company is India-domestic; Nexus partners are deeply context-aware on Indian healthcare’s unusual structure (out-of-pocket-heavy, fragmented hospital chains, variable digital infrastructure) and will engage on those questions. Caveats: India healthcare-tech has a different unit-economics structure than US healthcare-tech, with lower ARPU and longer payback periods, and Nexus knows that, but founders should be transparent about the implications for capital efficiency and runway; the firm takes board seats and is engaged post-investment; valuations are at market for India; and partner involvement varies by partner, so as always, the partner-specific reference call matters more than the firm’s overall brand.